News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Provista Diagnostics (PDx) Announces the Closing of Additional $2.5 Million Series A Preferred Financing


9/18/2012 9:44:46 AM

Scottsdale, Arizona, Sept. 18, 2012 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a provider of oncology-based diagnostic tests and clinical laboratory services to the pharmaceutical and biotechnology industries, today announced that it has sold an additional $2.5 million of Series A preferred stock to qualified institutional and individual investors. This closing brings the total amount raised in the offering to $7.5 million; $5.0 million of Series A preferred stock was previously sold in February and March. Participation in this latest round of funding was offered exclusively to existing shareholders of the company.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES